Assignee
MEREO BIOPHARMA 1 LTD
GB·10 granted patents·3 pending applications·18 citations·filing 2013–2021
Top patents by PatentIndex Score
13 records- 0188US10603306B2Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2016·Granted Mar 31, 2020·5 cites·20 claims
- 0278US10617674B2Dosage regimen for the treatment of acute exacerbations of inflammatory conditionsMEREO BIOPHARMA 1 LTD·Filed 2016·Granted Apr 14, 2020·4 cites·16 claims
- 0375US9339491B2Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2013·Granted May 17, 2016·7 cites·11 claims
- 0472US10934260B2Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamideMEREO BIOPHARMA 1 LTD·Filed 2017·Granted Mar 2, 2021·1 cites·16 claims
- 0570US11234967B2Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2018·Granted Feb 1, 2022·1 cites·20 claims
- 0660US11434204B2Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamideMEREO BIOPHARMA 1 LTD·Filed 2021·Granted Sep 6, 2022·0 cites·6 claims
- 0759US11129810B2Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2020·Granted Sep 28, 2021·0 cites·16 claims
- 0849US11701341B2Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2018·Granted Jul 18, 2023·0 cites·10 claims
- 0947US11649213B2Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compoundMEREO BIOPHARMA 1 LTD·Filed 2019·Granted May 16, 2023·0 cites·17 claims
- 1041US10995071B2Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamideMEREO BIOPHARMA 1 LTD·Filed 2017·Granted May 4, 2021·0 cites·23 claims
- 1141US2022033352A1Synthetic method for the preparation of an alkoxymethylene-benzoylacetonitrileMEREO BIOPHARMA 1 LTD·Filed 2019·Application pending·0 cites
- 1240US2021340108A1Synthetic method for the preparation of an hydrazine compoundMEREO BIOPHARMA 1 LTD·Filed 2019·Application pending·0 cites
- 1334US2016243081A1Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary diseaseMEREO BIOPHARMA 1 LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEREO BIOPHARMA 1 LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →